PROCEPT BioRobotics (PRCT) Total Liabilities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Total Liabilities data on file, last reported at $139.4 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $139.4 million, up 7.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $139.4 million (up 7.05% YoY), and the FY2025 annual result was $142.2 million, up 7.9% from the prior year.
• Total Liabilities fell to $139.4 million in Q1 2026 per PRCT's latest filing, from $142.2 million in the prior quarter.
• Over five years, Total Liabilities peaked at $142.2 million in Q4 2025 and troughed at $68.2 million in Q1 2022.
• A 5-year average of $118.0 million and a median of $122.6 million in 2024 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities plunged 65.23% in 2022, then soared 63.33% in 2023.
• A 5-year view of Total Liabilities shows it stood at $112.3 million in 2022, then advanced by 10.43% to $124.0 million in 2023, then climbed by 6.32% to $131.8 million in 2024, then rose by 7.9% to $142.2 million in 2025, then fell by 1.98% to $139.4 million in 2026.
• Business Quant data shows PRCT's Total Liabilities at $139.4 million in Q1 2026, $142.2 million in Q4 2025, and $131.3 million in Q3 2025.